Cash
£4.92M
120.77%
Net Worth
£35.24M
57.04%
Total Current Assets
£68.89M
31.77%
Total Current Liabilities
£42.72M
44.78%
FORTREA CLINICAL RESEARCH UNIT LIMITED
Private limited with Share Capital
Active - Accounts Filed
17 October 1991
74909 Other professional, scientific and technical activities n.e.c. - Other professional, scientific and technical activities n.e.c.
Available to 23 Dec 2025. Next accounts due by 30 Sep 2026
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mrs Agnieszka Moskal Gallagher | Director | ||
| Ms Jill McConnell | Director | ||
| Mr David Cooper | Director |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
2
Total Satisfied
0
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Goldman Sachs Bank Usa As Collateral Agent | OUTSTANDING | |||
| U.s. Bank Trust Company, National Association As Collateral Agent | OUTSTANDING |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £4,921,000.00 | £2,229,000.00 | £7,355,000.00 | £4,365,000.00 | £3,525,000.00 |
| Net Worth | £35,242,000.00 | £82,030,000.00 | £69,249,000.00 | £53,405,000.00 | £38,716,000.00 |
| Total Current Liabilities | £42,721,000.00 | £29,508,000.00 | £28,800,000.00 | £25,243,000.00 | £33,822,000.00 |
| Total Current Assets | £68,893,000.00 | £100,974,000.00 | £93,637,000.00 | £80,231,000.00 | £79,690,000.00 |
View Full Accounts
Accounts Table
| Profit & Loss | |||||
|---|---|---|---|---|---|
| Weeks | 52 | 52 | 52 | 52 | 52 |
| Currency | GBP | GBP | GBP | GBP | GBP |
| Consolidated Accounts | N | N | N | N | N |
| Turnover | £59,444,000 | £63,143,000 | £69,594,000 | £51,696,000 | £41,140,000 |
| Cost of Sales | £19,939,000 | £20,053,000 | £27,952,000 | £19,245,000 | £10,352,000 |
| Gross Profit | £39,505,000 | £43,090,000 | £41,642,000 | £32,451,000 | £30,788,000 |
| Wages & Salaries | - | - | - | - | - |
| Directors Emoluments | - | - | - | - | - |
| Operating Profit | £12,503,000 | £16,185,000 | £17,310,000 | £10,331,000 | £10,920,000 |
| Depreciation | £2,024,000 | £1,479,000 | £265,000 | £247,000 | £248,000 |
| Audit Fees | £31,000 | £29,000 | £26,000 | £22,000 | £16,000 |
| Interest Payments | £655,000 | £42,000 | £53,000 | £107,000 | £105,000 |
| Pre Tax Profit | £13,264,000 | £18,137,000 | £18,314,000 | £11,021,000 | £11,580,000 |
| Tax | - | - | - | - | - |
| Profit After Tax | £1,759,000 | £12,848,000 | £14,982,000 | £10,744,000 | £10,700,000 |
| Dividends Payable | £49,436,000 | - | - | - | - |
| Retained Profit | - | £12,848,000 | £14,982,000 | £10,744,000 | £10,700,000 |
| Export | £37,703,000 | £36,698,000 | £41,132,000 | £29,432,000 | £28,060,000 |
| Balance Sheet | |||||
|---|---|---|---|---|---|
| Tangible Assets | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Total Fixed Assets | £23,777,000 | £25,105,000 | £14,808,000 | £2,401,000 | £2,171,000 |
| Stock | - | - | - | - | - |
| Trade Debtors | £29,281,000 | £16,525,000 | £36,538,000 | £19,777,000 | £11,978,000 |
| Cash | £4,921,000 | £2,229,000 | £7,355,000 | £4,365,000 | £3,525,000 |
| Other Debtors | £34,691,000 | £82,220,000 | £49,744,000 | £56,089,000 | £64,187,000 |
| Miscellaneous Current Assets | - | - | - | - | - |
| Total Current Assets | £68,893,000 | £100,974,000 | £93,637,000 | £80,231,000 | £79,690,000 |
| Trade Creditors | £2,240,000 | £3,250,000 | £646,000 | £201,000 | £159,000 |
| Bank Loans And Overdrafts | - | - | - | - | - |
| Other Short Term Finance | £17,736,000 | £10,662,000 | £8,585,000 | £9,086,000 | £14,305,000 |
| Miscellaneous Current Liabilities | £15,248,000 | £10,547,000 | £13,658,000 | £11,092,000 | £15,006,000 |
| Total Current Liabilities | £42,721,000 | £29,508,000 | £28,800,000 | £25,243,000 | £33,822,000 |
| Bank Loans And Overdrafts And LTL | £14,707,000 | £14,541,000 | £10,396,000 | £3,984,000 | £9,323,000 |
| Other Long Term Finance | - | - | - | - | - |
| Total Long Term Finance | - | - | - | - | - |
| Capital & Reserves | |||||
|---|---|---|---|---|---|
| Called Up Shared Capital | - | - | - | - | - |
| P & L Account Reserve | £35,242,000 | £82,030,000 | £69,249,000 | £53,405,000 | £38,716,000 |
| Revaluation Reserve | - | - | - | - | - |
| Sundry Reserves | - | - | - | - | - |
| Shareholder Funds | - | - | - | - | - |
| Other Financial Items | |||||
|---|---|---|---|---|---|
| Net Worth | £35,242,000 | £82,030,000 | £69,249,000 | £53,405,000 | £38,716,000 |
| Working Capital | £26,172,000 | £71,466,000 | £64,837,000 | £54,988,000 | £45,868,000 |
| Total Assets | £92,670,000 | £126,079,000 | £108,445,000 | £82,632,000 | £81,861,000 |
| Total Liabilities | £57,428,000 | £44,049,000 | £39,196,000 | £29,227,000 | £43,145,000 |
| Net Assets | £35,242,000 | £82,030,000 | £69,249,000 | £53,405,000 | £38,716,000 |
| Cash | |||||
|---|---|---|---|---|---|
| Net Cash Flow From Operations | - | - | - | - | - |
| Net Cash Flow Before Financing | - | - | - | - | - |
| Net Cash Flow From Financing | - | - | - | - | - |
| Increase In Cash | - | - | - | - | - |
| Miscellaneous | |||||
|---|---|---|---|---|---|
| Contingent Liability | N | N | N | N | N |
| Capital Employed | £49,949,000 | £96,571,000 | £79,645,000 | £57,389,000 | £48,039,000 |
| Number Of Employees | 353 | 363 | 331 | 307 | 288 |
| Auditors | - | - | - | - | - |
| Auditor Comments | The audit report contains no adverse comments | The audit report contains no adverse comments | The audit report contains no adverse comments | The audit report contains no adverse comments | The audit report contains no adverse comments |
| Ratios | |||||
|---|---|---|---|---|---|
| Pre-tax Profit Margin | 22.31 | 28.72 | 26.32 | 21.32 | 28.15 |
| Current Ratio | 1.61 | 3.42 | 3.25 | 3.18 | 2.36 |
| sales Networking Capital | 2.27 | 0.88 | 1.07 | 0.94 | 0.9 |
| Gearing | 41.73 | 17.73 | 15.01 | 7.46 | 24.08 |
| Equity In % | 38.03 | 65.06 | 63.86 | 64.63 | 47.29 |
| Creditor Days | 13.75 | 18.79 | 3.39 | 1.42 | 1.41 |
| Liquidity/Acid Test | 1.61 | 3.42 | 3.25 | 3.18 | 2.36 |
| Return on Capital Employed % | 26.56 | 18.78 | 22.99 | 19.2 | 24.11 |
| Return on Total Assets Employed % | 14.31 | 14.39 | 16.89 | 13.34 | 14.15 |
| Current Debt Ratio | 1.21 | 0.36 | 0.42 | 0.47 | 0.87 |
| Total Debt Ratio | 1.63 | 0.54 | 0.57 | 0.55 | 1.11 |
| Stock Turnover Ratio % | 0 | 0 | 0 | 0 | 0 |
| Return on Net Assets Employed % | 37.64 | 22.11 | 26.45 | 20.64 | 29.91 |